… triggered by COVID-19 vaccine: Rapid resolution with corticosteroid therapy Dear Editor,
Bullous pemphigoid (BP) is an acquired autoimmune blistering disease characterized by …

… Autoimmune blistering diseases (AIBD) are a group of chronic … start therapy for our patients
with BP with prednisone in a dose of 0.5 mg/kg/day with addition of topical corticosteroids on …

… Thereafter, members of the EADV Task force Autoimmune blistering diseases (notation … a
0.5 mg/kg/day starting dose of prednisone allows disease control to be achieved at day 21 in 75…

… There is a paucity of literature on pediatric autoimmune bullous disorders (AIBD) in the Indian
… prolonged therapy with corticosteroids and achieved complete remission off therapy 18 …

… The goal of the treatment of autoimmune bullous disease is to reduce the production of
pathogenic … drug to be combined with corticosteroid in the management of autoimmune bullous …

… disease activity in all autoimmune blistering diseases. This score assesses the degree of …
membrane pemphigoid; ie, with agents such as rituximab, prednisone, dapsone, or IVIG. …

… approach and treatment of patients with autoimmune bullous diseases (AΙBD). We processed
… suppressive agents was used as a therapeutic option beyond systemic corticosteroids in …

… Autoimmune blistering diseases negatively impacts upon work productivity and activity. …
of prednisone, which was scored from 0 to 3, and any adjuvant immunosuppressive therapy, …

… Steroid-sparing agents can be added to glucocorticoid … 20 years studying autoimmune
bullous diseases; finally the main treatment options and the prognostic factors of the disease are …

… human papillomavirus (Gardasil) Pemphigoid (n = 2), PV (n = 1) … and autoimmune diseases
including PV, PF, and pemphigoid. … after topical/oral corticosteroids Exacerbation after the …